Clincosm LogoSign in Get a demo

pneumococcal infection

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pneumococcal Infection Trial (V116, Placebo for PCV15 + PPSV23, PCV15)

Not yet recruiting
  • Pneumococcal Infection
  • V116
  • +3 more
  • (no location specified)
Jan 13, 2023

Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)

Recruiting
  • Pneumococcal Infection
  • V110
  • +4 more
  • North Hollywood, California
  • +45 more
Aug 11, 2022

Pneumococcal Infection, Streptococcus Pneumoniae Infection, Invasive Pneumococcal Disease, Protection Against Trial in Kilifi

Active, not recruiting
  • Pneumococcal Infection
  • +2 more
  • PCV10
  • PCV13
  • Kilifi, Kenya
    KEMRI Wellcome Trust Research Programme
Feb 23, 2022

Pneumococcal Infection Trial (Pneumo 23® 0,5, Pneumo 23® 0,1, Prevenar13® 0,5)

Completed
  • Pneumococcal Infection
  • Pneumo 23® 0,5
  • +2 more
  • (no location specified)
Jul 31, 2021

Pneumococcal Infection Trial in Fukuoka, Kumamoto (pPCV, PNEUMOVAX™23)

Completed
  • Pneumococcal Infection
  • pPCV
  • PNEUMOVAX™23
  • Fukuoka, Japan
  • +1 more
Apr 16, 2021

Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia Trial in Minsk (Vaccination with pneumococcal conjugate vaccine

Enrolling by invitation
  • Multiple Myeloma
  • +3 more
  • Vaccination with pneumococcal conjugate vaccine (PCV13)
  • Standard Antibacterial Prophylaxis
  • Minsk, Belarus
    Minsk Scientific Practical Center of Surgery, Transplantation an
Sep 1, 2020

Pathogen Resistance, Pneumococcal Infection, Pneumonia Trial in Baltimore, Cleveland (Colistimethate sodium)

Terminated
  • Pathogen Resistance
  • +2 more
  • Colistimethate sodium
  • Baltimore, Maryland
  • +1 more
Feb 27, 2020

Pneumococcal Infection Trial in Seoul (LBVE, Prevnar13)

Completed
  • Pneumococcal Infection
  • LBVE
  • Prevnar13
  • Seoul, Gangseo-Gu, Korea, Republic of
    LG chem
Aug 21, 2019

Pneumococcal Infection Trial (PNEUMOVAX™ 23)

Completed
Has Results
  • Pneumococcal Infection
  • PNEUMOVAX™ 23
  • (no location specified)
Oct 1, 2018

Pneumococcal Infection Trial in Decatur (PNEUMOVAX, Prevnar)

Completed
Has Results
  • Pneumococcal Infection
  • PNEUMOVAX
  • Prevnar
  • Decatur, Georgia
  • +1 more
Sep 28, 2018

Pneumococcal Infection Trial in Huaian, Nanjing (13-valent Pneumococcal Conjugate Vaccine)

Completed
  • Pneumococcal Infection
  • 13-valent Pneumococcal Conjugate Vaccine
  • Huaian, Jiangsu, China
  • +1 more
Sep 6, 2018

Pneumococcal Infection Trial (LBVE01, LBVE02, Prevnar13)

Unknown status
  • Pneumococcal Infection
  • LBVE01
  • +2 more
  • (no location specified)
Jun 11, 2018

Thalassemia, Pneumococcal Infection Trial in Jakarta Pusat (dietary supplement, drug, biological)

Completed
  • Thalassemia
  • Pneumococcal Infection
  • Zinc
  • +3 more
  • Jakarta Pusat, Jakarta, Indonesia
    Fakultas Kedokteran Universitas Indonesia
Mar 28, 2017

Pneumococcal Infection Trial in United States (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])

Completed
Has Results
  • Pneumococcal Infection
  • Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]
  • Decatur, Georgia
  • +6 more
Feb 23, 2017

Pneumococcal Infection Trial (Pneumococcal Vaccine, Polyvalent (23-valent))

Completed
  • Pneumococcal Infection
  • Pneumococcal Vaccine, Polyvalent (23-valent)
  • (no location specified)
Mar 13, 2017

Pneumococcal Infection Trial in Merthyr Tydfil (PnuBioVax, Placebo)

Completed
  • Pneumococcal Infection
  • PnuBioVax
  • Placebo
  • Merthyr Tydfil, Glamorgan, United Kingdom
    Simbec Research Ltd
Oct 4, 2016

Residual Anti-pneumococcal Immunity After Pneumococcal

Completed
  • Pneumococcal Infection
  • ANCA-associated Vasculitis
    • Paris, Ile de France, France
      AP-HP ; Cochin Hospital
    Aug 18, 2016

    Immunogenicity ofCombined Anti-pneumococcal Vaccine Schedule in

    Unknown status
    • Pneumococcal Infection
    • ANCA-associated Vasculitis
      • Paris, Ile de France, France
        AP-HP ; Cochin Hospital
      Feb 24, 2016

      Pneumococcal Infection Trial in Toledo (23-valent pneumococcal polysaccharide vaccine, 13-valent pneumococcal conjugate vaccine)

      Completed
      • Pneumococcal Infection
      • 23-valent pneumococcal polysaccharide vaccine
      • 13-valent pneumococcal conjugate vaccine
      • Toledo, Ohio
        The University of Toledo-Health Science Campus
      Sep 23, 2015

      Pneumococcal Infection Trial in Toledo (PPV23)

      Completed
      • Pneumococcal Infection
      • PPV23
      • Toledo, Ohio
        The University of Toledo-Health Science Campus
      Aug 5, 2015

      Pneumococcal Infection Trial in Rochester, Cincinnati (Placebo, PNU-IMUNE®23, Nine-valent pneumococcal conjugate (PNCRM9))

      Completed
      • Pneumococcal Infection
      • Placebo
      • +2 more
      • Rochester, New York
      • +1 more
      Oct 16, 2014

      Pneumococcal Infection Trial in Guanyun County,, Huaian City, Lianshui County (7-valent Pneumococcal Conjugate Vaccine,

      Completed
      • Pneumococcal Infection
      • 7-valent Pneumococcal Conjugate Vaccine
      • 13-valent Pnumococcal Conjugate vaccine
      • Guanyun County,, Jiangsu, China
      • +3 more
      Jul 15, 2014

      Pneumococcal Infection, Influenza Trial in Zhenjiang (23-valent pneumococcal polysaccharide vaccine, trivalent influenza

      Completed
      • Pneumococcal Infection
      • Influenza
      • 23-valent pneumococcal polysaccharide vaccine
      • +2 more
      • Zhenjiang, Jiangsu, China
        Yangzhong Center for Disease Control and Prevention
      Feb 12, 2014

      Pneumococcal Infection in Ministry of Health Hospital at EHSA

      Unknown status
      • Pneumococcal Infection
      • serotypes and resistance
      • (no location specified)
      Feb 13, 2009